| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 09/29/2011 | US20110239311 Agonists of NR2F6 For Immunosupression |
| 09/29/2011 | US20110238186 Preparation of regenerative tissue scaffolds |
| 09/29/2011 | US20110237783 Hydrazonopyrazole derivatives and their use as therapeutics |
| 09/29/2011 | US20110237671 Cosmetic composition comprising vitamin u as active ingredient for healing wounds and reducing wrinkles |
| 09/29/2011 | US20110237667 Compositions Containing Diethanol Amine Esterquats |
| 09/29/2011 | US20110237660 Oral composition |
| 09/29/2011 | US20110237659 Chromenone derivatives as trpv3 antagonists |
| 09/29/2011 | US20110237650 Treatment of vascular endothelial growth factor (vegf) related diseases by inhibition of natural antisense transcript to vegf |
| 09/29/2011 | US20110237649 Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirtuin 1 |
| 09/29/2011 | US20110237648 Rna interference in skin indications |
| 09/29/2011 | US20110237638 Metronidazole-based dermatological foam and emulsions for the preparation thereof |
| 09/29/2011 | US20110237637 Metronidazole-based dermatological foam and emulsions for the production thereof |
| 09/29/2011 | US20110237631 Selective Glycosidase Inhibitors and Uses Thereof |
| 09/29/2011 | US20110237617 Thieno[2,3-c] isoquinolines for use as inhibitors of parp |
| 09/29/2011 | US20110237601 Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonists |
| 09/29/2011 | US20110237599 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 09/29/2011 | US20110237593 Topical anti-pruritic compositions and methods of action of same |
| 09/29/2011 | US20110237585 Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase |
| 09/29/2011 | US20110237583 2, 5-diamino-substituted pyrido [4, 3-d] pyrimidines as autotaxin inhibitors against cancer |
| 09/29/2011 | US20110237574 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 09/29/2011 | US20110237573 N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as wnt signaling modulators |
| 09/29/2011 | US20110237565 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 09/29/2011 | US20110237558 Stabilized composition for treating psoriasis |
| 09/29/2011 | US20110237557 Diastereomers of 2-methylene-19-nor-22-methyl-1alpha,25-dihydroxyvitamin d3 |
| 09/29/2011 | US20110237556 (20S)-2-METHYLENE-19-NOR-22-DIMETHYL-1alpha,25-DIHYDROXYVITAMIN D3 AND (20R)-2-METHYLENE-19-NOR-22-DIMETHYL-1alpha,25-HYDROXYVITAMIN D3 |
| 09/29/2011 | US20110237555 Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of rosacea |
| 09/29/2011 | US20110237551 Para-Coumaric Acid or Para-Hydroxycinnamic Acid Derivatives and Their Use in Cosmetic or Dermatological Compositions |
| 09/29/2011 | US20110237542 Composition for preventing adhesion |
| 09/29/2011 | US20110237527 Sglt-2 inhibitors, methods of making them, and uses thereof |
| 09/29/2011 | US20110237521 Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease |
| 09/29/2011 | US20110237517 Iap inhibitors |
| 09/29/2011 | US20110237516 Plant-derived elastin binding protein ligands and methods of using the same |
| 09/29/2011 | US20110237497 Compositions of a v-atpase inhibitor in combination with a glucocorticoid receptor ligand and methods of use |
| 09/29/2011 | US20110236513 Substances capable of potentiating laminin 5 productivity in epidermal cells and their use |
| 09/29/2011 | US20110236509 Topical composition comprising extracts of a. indica and m. charantia or s. indicum |
| 09/29/2011 | US20110236503 Topical Skincare Composition |
| 09/29/2011 | US20110236501 Injectable dual delivery allograph bone/polymer composite for treatment of open fractures |
| 09/29/2011 | US20110236499 Dermal compositions containing gorgonian extract |
| 09/29/2011 | US20110236486 Method to produce hyaluronic acid functionalized derivatives and formation of hydrogels thereof |
| 09/29/2011 | US20110236440 Medical tape preparation |
| 09/29/2011 | US20110236438 Method of treatment of diseases using hoodia extracts |
| 09/29/2011 | US20110236434 Polymorphic Forms of ST-246 and Methods of Preparation |
| 09/29/2011 | US20110236433 Wound care device |
| 09/29/2011 | US20110236430 Method for controlling toxicity of metallic particle and low-toxicity composite of metallic nanoparticle and inorganic clay |
| 09/29/2011 | US20110236390 IL-17A Antagonists |
| 09/29/2011 | US20110236367 Rat cathespin dipeptidyl peptidase i (dppi): crystal structure and its uses |
| 09/29/2011 | US20110236352 PEGylation by the Dock and Lock (DNL) Technique |
| 09/29/2011 | US20110236330 Skin Whitening |
| 09/29/2011 | US20110236326 Skin Whitener |
| 09/29/2011 | US20110236325 Methods to treat or prevent a skin condition using a nell1 peptide |
| 09/29/2011 | US20110236321 Aerosol Foams Comprising Clindamycin Phosphate |
| 09/29/2011 | DE19724456B4 Medizinische Mischungszusammensetzung mit lang anhaltender Arzneimittelabgabemöglichkeit Medical mixture composition with sustained drug delivery option |
| 09/29/2011 | DE102010016134A1 Producing a concentrate from camel milk, useful in pharmaceutical or cosmetic composition for treating skin diseases, comprises preparing cream from camel milk, stirring the cream and separating the camel milk water |
| 09/29/2011 | DE102010013081A1 Antimikrobielle Öl in Wasser Emulsion Antimicrobial oil in water emulsion |
| 09/29/2011 | CA2831036A1 Dermal compositions containing gorgonian extract |
| 09/29/2011 | CA2794503A1 Aerosol foams comprising clindamycin phosphate |
| 09/29/2011 | CA2794006A1 (20s)-2-methylene-19-nor-22-dimethyl-1.alpha.,25-dihydroxyvitamin d3 and (20r)-2-methylene-19-nor-22-dimethyl-1.alpha.,25-hydroxyvitamin d3 |
| 09/29/2011 | CA2793985A1 Proangiogenic compositions, method for preparing same, and uses thereof |
| 09/29/2011 | CA2793725A1 Carboxamide bioisosteres of opiates |
| 09/29/2011 | CA2793533A1 Polymorphic forms of st-246 and methods of preparation |
| 09/29/2011 | CA2793085A1 Anti-allergic agent |
| 09/29/2011 | CA2792883A1 Compositions and methods for prevention and treatment of wounds |
| 09/29/2011 | CA2792649A1 Improved methods and compositions for safe and effective treatment of telangiectasia |
| 09/29/2011 | CA2792646A1 Improved uses and compositions for safe and effective treatment of erythema |
| 09/28/2011 | EP2368974A1 Methods for isolating mesenchymal stem cells from embryos of human or animals and extracting secretion substances thereof |
| 09/28/2011 | EP2368910A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 09/28/2011 | EP2368898A1 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 09/28/2011 | EP2368577A2 Methods for treating interleukin-6 related diseases |
| 09/28/2011 | EP2368562A1 Compositions and methods for inducing melanogenesis in a subject |
| 09/28/2011 | EP2368557A1 Methods of simultaneously treating ocular rosacea and acne rosacea |
| 09/28/2011 | EP2367564A1 Norrin in the treatment of diseases associated with an increased tgf-beta activity |
| 09/28/2011 | EP2148876B1 Pyrazolone derivatives as pde4 inhibitors |
| 09/28/2011 | EP1673058B1 Composition and method for promoting hair growth |
| 09/28/2011 | EP1463531B1 Methods for inhibiting ocular processes |
| 09/28/2011 | EP1421191B1 Humanised antibodies specific for both CD45RB and CD45RO |
| 09/28/2011 | EP1420800B1 Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at 4) receptor activity |
| 09/28/2011 | EP1237891B1 Heterocyclic dihydropyrimidines as potassium channel inhibitors |
| 09/28/2011 | CN201986748U 透气防护面料 Breathable protective fabrics |
| 09/28/2011 | CN1344159B Combinations for treatment of diseases involving angiogenesis |
| 09/28/2011 | CN102203085A Processes for the preparation of crystalline forms of sunitinib malate |
| 09/28/2011 | CN102202659A Therapeutic, dietary, or cosmetic use of compounds with specific anti-apoptotic activity toward caspase-3, and compositions containing these compounds |
| 09/28/2011 | CN102202651A Topical formulation of 3-(2,2,2-trimethylhydrazinium) propionate dihydrate |
| 09/28/2011 | CN102199489A Extraction method and formula of litsea cubeba compound essential oil |
| 09/28/2011 | CN102199144A Benzimidazole derivatives |
| 09/28/2011 | CN102198257A Chinese medicinal powder for treating psoriasis |
| 09/28/2011 | CN102198255A Alopecia preventing and hair growing composition |
| 09/28/2011 | CN102198254A Specially-made Chinese medicine spray for killing hair bugs |
| 09/28/2011 | CN102198247A Formula of Chinese medicine for treating whelk |
| 09/28/2011 | CN102198212A Chinese medicinal liquid for treating burns and scalds and preparation method thereof |
| 09/28/2011 | CN102198200A Quick-acting swelling-diminishing and pain-relieving tincture |
| 09/28/2011 | CN102198196A External washing agent for treating dermatophytosis |
| 09/28/2011 | CN102198190A Traditional Chinese medicine lotion for external washing and composition ointment for external application for treating burn and scald |
| 09/28/2011 | CN102198186A Medicament for external use for preventing and treating chilblain, and preparation method thereof |
| 09/28/2011 | CN102198175A Chinese medicine composition |
| 09/28/2011 | CN102198164A Sugar-free aqua lonicerae foliae capable of keeping original fragrance |
| 09/28/2011 | CN102198159A Medicament for the treatment of burns and sore and ulcer diseases, and wound plaster made of the same |
| 09/28/2011 | CN102198156A Pharmaceutical composition for treatment of skin wound |
| 09/28/2011 | CN102198153A Nano-silver spray for treating skin diseases, and preparation method thereof |
| 09/28/2011 | CN102198128A Artificial cell heal membrane and preparation method thereof |
| 09/28/2011 | CN102197887A Health-care brassiere made of Apocynum venetum Linn |